Ardeparin Terminated Phase 2 Trials for Thrombosis Prophylaxis (Risk of Thrombosis Due to Central Venous Line (CVL) Prevention

IndicationsStatusPurposePhase
TerminatedPrevention2
clinicaltrials.gov IdentifierTitleDrugs
NCT01567904Study of AVE5026 at Weight-adjusted Doses in Children With a Central Venous Line